Sionna Therapeutics, Inc. (SION)

Sionna Therapeutics, Inc. (SION) is a healthcare company (biotechnology) based in the United States. The share price is $3.07, down 1.76% on the day, which values the company at $138.65M. Price as of 17 Nov 2026, 17:28 UTC, from Yahoo Finance.

Key facts

Share price
$3.07−1.76% today
Market value
$138.65M
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Sionna Therapeutics, Inc. in more detail

SION trades at -1.3× next year's expected earnings.

In its favour: More cash than debt.

3 of the superinvestors tracked here hold SION, including Peter Kolchinsky (3.8% of the portfolio), Andreas Halvorsen (0.4% of the portfolio), Julian and Felix Baker (0.1% of the portfolio).

Superinvestors holding SION

3 of the investors tracked here report a position in their latest 13F filing.

Sionna Therapeutics, Inc. (SION): questions and answers

What is Sionna Therapeutics, Inc.'s market cap?

Sionna Therapeutics, Inc. is valued at $138.65M at a share price of $3.07.

Does SION pay a dividend?

Sionna Therapeutics, Inc. does not currently pay a regular dividend.

Which famous investors own SION?

In their latest quarterly filings, Peter Kolchinsky (3.8% of the portfolio), Andreas Halvorsen (0.4% of the portfolio), Julian and Felix Baker (0.1% of the portfolio) hold SION. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Sionna Therapeutics, Inc. (SION) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/SION

Underlying data: Yahoo Finance; company filings with the SEC.